|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 102, Issue 2 361-368, Copyright © 1988 by Company of Biologists
JOURNAL ARTICLES |
B Raynaud, N Faucon-Biguet, S Vidal, J Mallet and MJ Weber
Laboratoire de Pharmacologie et Toxicologie Fondamentales CNRS-205, Toulouse, France.
The survival of new-born rat sympathetic neurones in culture was increased in a dose-dependent manner by 7S nerve growth factor (NGF). NGF also increased, in a parallel manner, the specific activities of tyrosine hydroxylase (TOH) and choline acetyltransferase (CAT). Total acetylcholinesterase (AcChE) activity increased with NGF concentration, although less distinctly than TOH and CAT. However, NGF caused a large induction of the asymmetric A12 form of AcChE, and to a lesser extent of the globular G1 and G2 forms, whereas the globular G4 form was little affected. This suggests that NGF differentially regulates the synthesis and/or assembly of the various AcChE molecular forms. The levels of TOH mRNA in neurone cultures grown with increasing NGF concentrations were measured by Northern blot analysis with a rat cDNA probe. To correct for variations in the total mass of RNA per neurone, the filters were rehybridized with an 18S rRNA probe. The level of TOH mRNA, measured by the ratio (TOH:18S) of the hybridization signals increased 3.4-fold between 92 and 740 ng ml-1 7S NGF. Increases of TOH specific activity of the same order of magnitude were observed in sister cultures. The deficit in the level of mature TOH mRNA at low NGF concentration was not accompanied by a compensatory accumulation in unprocessed TOH transcripts. As TOH induction is insensitive to RNA polymerase inhibitors, we suggest that NGF regulates the maturation of TOH pre-mRNAs, and that the unprocessed transcripts are rapidly degraded. The long-term regulation of TOH by NGF may thus constitute a case of process-versus-discard control, as defined by J.E. Darnell.
This article has been cited by other articles:
|
|
 |
|
  M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Shadiack, Y. Sun, and R. E. Zigmond Nerve Growth Factor Antiserum Induces Axotomy-Like Changes in Neuropeptide Expression in Intact Sympathetic and Sensory Neurons J. Neurosci., January 15, 2001; 21(2): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J.L. Fernandes, N. R. Kobayashi, B. J. Jasmin, and W. Tetzlaff Acetylcholinesterase Gene Expression in Axotomized Rat Facial Motoneurons Is Differentially Regulated by Neurotrophins: Correlation with trkB and trkC mRNA Levels and Isoforms J. Neurosci., December 1, 1998; 18(23): 9936 - 9947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Lockhart, G. G. Turrigiano, and S. J. Birren Nerve Growth Factor Modulates Synaptic Transmission between Sympathetic Neurons and Cardiac Myocytes J. Neurosci., December 15, 1997; 17(24): 9573 - 9582. [Abstract] [Full Text] [PDF]
|
|
